Valuation Astal Laboratories Limited

Stocks

Delayed Bombay S.E. 03:14:50 2026-11-06 am EST			5-day change	1st Jan Change
60.77 ^INR	+0.80%		-1.56%	-30.06%

Aug. 14	Astal Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
May. 30	Astal Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	34.77	64.34	118.1	401.9	747.2	2,759
Change	-	85.03%	83.54%	240.29%	85.93%	269.28%
Enterprise Value (EV) ¹	34.46	64.16	117.2	344.2	862.6	3,251
Change	-	86.18%	82.75%	193.57%	150.59%	276.91%
P/E	577x	-376x	722x	26.3x	9.45x	8.37x
PBR	0.67x	1.25x	2.27x	1.72x	2.08x	0.83x
PEG	-	1x	-4x	0x	0x	-2.89x
Capitalization / Revenue	17.2x	30.5x	3.27x	1.7x	1.17x	1.11x
EV / Revenue	17.1x	30.4x	3.25x	1.45x	1.36x	1.31x
EV / EBITDA	-	-	-	-	-	-
EV / EBIT	-	-	-	-	-	-
EV / FCF	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.0152	-0.0431	0.041	1.554	8.043	7.81
Distribution rate	-	-	-	-	-	-
Net sales ¹	2.019	2.108	36.07	236.6	636.6	2,486
EBITDA	-	-	-	-	-	-
EBIT	-	-	-	-	-	-
Net income ¹	0.0602	-0.1711	0.164	7.847	89.25	147.1
Net Debt ¹	-0.3129	-0.1828	-0.844	-57.64	115.4	491.9
Reference price ²	8.75	16.19	29.60	40.88	76.01	65.36
Nbr of stocks (in thousands)	3,974	3,974	3,990	9,830	9,830	42,216
Announcement Date	9/1/21	9/8/22	8/25/23	7/12/24	8/18/25	9/7/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ASTAL LABORATORIES LIMITED	-	-	-	-	27.94M
ELI LILLY AND COMPANY	39.94x	13.51x	30.01x	0.5%	1,216B
JOHNSON & JOHNSON	39.86x	6.69x	18.83x	1.96%	656B
ABBVIE INC.	37.08x	8.43x	17.39x	2.4%	509B
ROCHE HOLDING AG	21.12x	5.13x	12.77x	2.56%	384B
MERCK & CO., INC.	97.32x	5.95x	25.36x	2.32%	362B
NOVARTIS AG	23.5x	6.02x	14.53x	2.65%	311B
ASTRAZENECA PLC	24.85x	4.96x	13.98x	1.76%	293B
AMGEN INC.	28.41x	7.33x	12.69x	2.19%	249B
GILEAD SCIENCES, INC.	-40.11x	7.32x	45.99x	1.97%	208B
Average	30.22x	7.26x	21.28x	2.03%	418.78B
Weighted average by Cap.	35.88x	8.57x	22.23x	1.73%